Preetam Shah - Sep 1, 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
CFO & CBO
Signature
/s/ Preetam Shah
Stock symbol
CDTX
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/3/2021, 04:32 PM
Next filing
Nov 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDTX Stock Option (right to buy) Award $0 +312K $0.00 312K Sep 1, 2021 Common Stock 312K $2.22 Direct F1
transaction CDTX Restricted Stock Unit Award $0 +50K $0.00 50K Sep 1, 2021 Common Stock 50K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of September 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on September 1, 2025.
F2 Restricted stock units convert into common stock on a one-for-one basis.
F3 The RSU will fully vest upon the completion of certain corporate milestones on or before September 30, 2022.